Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Appendix B: Drug Characteristics Tables
Characteristics of CCR5 Antagonist
Last Updated: March 27, 2012; Last Reviewed: April 8, 2015
||14-18 hours||CYP3A4 substrate||
a For dosage adjustment in hepatic insufficiency, see Appendix B, Table 7.
b Also see Table 14.
Key to Abbreviations: BID = twice daily; CYP = cytochrome P; EFV = efavirenz; ETR = etravirine; MVC = maraviroc; NRTI = nucleoside reverse transcriptase inhibitor; NVP = nevirapine; PI = protease inhibitor; RAL = raltegravir; T20 = enfuvirtide; TPV/r = tipranavir/ritonavir